Whole pathogen multiplex controls to support testing for cold, cough and COVID

Home - Archives for October 2020

Whole pathogen multiplex controls to support testing for cold, cough and COVID

News       Coronavirus        Qnostics

 

27 October 2020

Whole pathogen multiplex controls to support testing for cold, cough and COVID

Just in time for flu season, global diagnostics company Randox Laboratories has unveiled a range of whole pathogen multiplex controls that cover multiple viral and bacterial pathogens which cause respiratory disease.

Inclusive of SARS-CoV-2, Influenza A & B, and Respiratory Syncytial Virus (RSV), the Qnostics Multiplex Respiratory Pathogen Controls (RTX) facilitate diagnosis of the likes of cold and flu, and importantly, the differentiation of these respiratory diseases from COVID-19.

Using a control line that covers a range of respiratory pathogens in this way will allow laboratories to streamline their testing, consolidate QC, and ultimately save time, money and resource.

Lynsey Adams, Randox Quality Control Manager, explained;     

“When the use of time and resources are critical such as in COVID-19 testing, the use of highly characterised controls enables laboratories to meet their daily QC needs and accreditation requirements.

“Accurate and reliable laboratory testing is an essential aspect of the management of COVID-19 and other respiratory diseases, so we are pleased to be able to offer these new controls which will crucially support the validation, verification and performance monitoring of molecular respiratory assays.”

The new RTX controls, which are whole pathogen for compatibility with the majority of commercial and in-house assays, are used to monitor the full testing process, from extraction to amplification and detection.

The Multiplex Respiratory Controls will support public health testing strategies during the incoming flu season and are suited for the test menus of most syndromic assays.

Lynsey continued;

“The Randox Qnostics Multiplex Respiratory Pathogen Controls are clinically relevant for full-process validation. Liquid frozen for user convenience and ease of use, the development of the controls using whole pathogen material ensures clinical relevance from extraction to amplification and detection.”

Randox Qnostics Multiplex Respiratory Pathogen Controls are manufactured to ISO 13485 standards and are in line with ISO 15189:2012 regulatory requirements.

Key Features and Benefits of the new RTX Controls:

  • Whole pathogen controls – the controls contain the entire genome meaning they are compatible with the majority of commercial and in-house assays.
  • Full process control – whole pathogen controls are the ideal material for full-process validation, monitoring the testing process from extraction to amplification and detection, to ensure ultimate quality assurance in laboratories.
  • Highly characterised – Qnostics controls are quantified by digital PCR to ensure batch to batch reproducibility and are traceable to an internal reference preparation, to ensure metrological traceability of test results obtained by different diagnostic workflows.
  • True Third Party – An independent, unbiased assessment of assay performance is ensured in line with ISO 15189:2012 regulatory requirements.
  • Superior ManufacturingQnostics controls are manufactured under ISO 13485 guidelines to ensure quality and traceability.
  • Liquid for Ease-of-Use – the controls are conveniently supplied in a liquid frozen format meaning there is no additional preparation or handling required.

For more information visit https://www.randox.com/molecular-infectious-disease-controls/respiratory-infection-testing/

For further enquiries please email marketing@randox.com

QNOSTICS

QCMD

CORONAVIRUS


Randox & Bosch Healthcare – Collaboratively Combating COVID-19

   

29th October 2020

Randox & Bosch Healthcare – Collaboratively Combating COVID-19

A game-changing partnership between Randox Laboratories and Bosch Healthcare Solutions continues to change the testing landscape and capabilities of both laboratory and non-laboratory settings in rapidly detecting COVID-19.

Providing clear and concise results, direct at the point of care, the Randox and Bosch Healthcare Solutions collaborative approach not only allows patients to take the recommended safety precautions without delay, but also provides a solution to both analyse and differentiate COVID-19 from other viral respiratory diseases. Multiple testing approaches with the same aim – to overcome COVID-19!

Combining science & technology, timing is of the essence in the fight against coronavirus. Together, we have combined efforts in successfully launching the Vivalytic – the all in one solution for molecular diagnostics consolidating nucleic acid extraction, polymerase chain reaction (PCR) and detection onto one small platform.

These efforts reflect a global partnership of both cooperation’s working together to deliver world-class diagnostic solutions, harnessing the power of innovation to improve health worldwide, providing an all in one approach minimising the spread of COVID-19 globally.

Launched after just six weeks at the beginning of the COVID-19 pandemic back in March 2020, the Viral Respiratory Infection array (VRI) set the benchmark for rapidly detecting SARS-CoV-2 (COVID-19) whilst simultaneously differentiating between nine other respiratory diseases, in under two and a half hours.

Proactively working together to combat the spread of COVID-19, Randox, Bosch Healthcare Solutions and R-Biopharm are proud to offer variable analysis strategies to detect SARS-CoV-2 (COVID-19). Capable of providing reliable results in just 39 minutes, with a sensitivity of 98% and specificity of 100%, the Vivalytic SARS-CoV-2 rapid test is currently among one of the fastest PCR tests worldwide.

Since the outbreak of COVID-19, we have significantly combined our efforts to provide a diverse range of testing solutions and approaches to meet the need of the rise in global cases. Our approaches have been utilised at all possible levels and together we open up a range of different testing strategies, with developments still underway with the upcoming release of the SARS-CoV-2 Pooling test.

The SARS-CoV-2 Pooling test is a rapid solution for the detection of SARS-CoV-2 (COVID-19) offering an accelerated decentral testing approach to effectively and efficiently monitor and detect viral infection from the offset. Capable of detecting SARS-CoV-2 (COVID-19) from up to five pooled samples simultaneously with a capacity to process more than 160 patient samples a day. The pooling could be done at the level of a ward, medical specialty, social bubble, or group of colleagues. It has potential for use in other settings, such as pre-operative screening, schools & universities, prisons, nursing homes, primary care, and large workplaces. Sample pooling allows more people to be tested quickly using fewer testing resources.

Partnering together, we continue to increase our testing capacity, enabling fully automated processing of patient samples to rapidly combat COVID-19.

Please contact marketing@randox.com for further information.

Randox in the media

Latest News

FAQs


U.S. Drug Overdose Deaths Resurge to Record During the Pandemic

News       About Us        Randox Toxicology

22 October 2020: U.S. Drug Overdose Deaths Resurge to Record During the Pandemic

Drug overdose deaths in the USA rose to a record high in 2019, after falling for the first time for 25 years in 2018. Almost 72,000 people died from drug overdoses in 2019 according to the preliminary data that was released by the Centres for Disease Control and Prevention earlier this year.

Though there is currently no hard data available, there is speculation that the pandemic is complicating and worsening the surge, as 2020 looks to be even more devastating than 2019. Data collected by The New York Times saw for the first half of 2020 drug overdose deaths have risen by an average of 13 percent across America compared to last year. If this trend continues into the rest of the year, it will be the sharpest rise in annual drug deaths since 2016, when fentanyl made its way into US drug trafficking and street supply.

Increased funding toward addiction treatment, prevision and recovery services did shows signs of improving overdose deaths. Though the government has made this positive headway in the last few years in how they tackle the drug epidemic in America, this progress could be threatened by the current COVID-19 pandemic.

Earlier in the month, Brett Giroir, the administration’s assistant secretary for health, said in a statement, “We understand that there is an extraordinary amount of work to do, especially now as we are also dealing with the Covid-19 pandemic that could markedly affect our nation’s mental health and risk of substance use.”

Several public health experts said conditions created by the pandemic could hurt the nation’s fragile progress in fighting the surge of drug deaths but noted that the overdose rate was on its way back up well before the virus arrived. “Covid just makes it a bit worse,” said Dr. Dan Ciccarone, a professor of medicine at the University of California, San Francisco, who studies the opioid epidemic. “It’s a small wave riding on top of a tsunami that continues to devastate.”

Although official statistics on 2020 overdose deaths won’t be available for a long time, there is local evidence showing drug related deaths are rising into 2020.

Increase in Drug related deaths from 2019 through the first portion of 2020

Though a lot of this data precedes the coronavirus pandemic, researchers believe there are several reasons why the virus could worsen the trend.

When state lockdowns first began in March, Dr. Anna Lembke, a clinician with Stanford’s Addiction Medicine Dual Diagnosis Clinic, noticed many of her patients showing signs of improving. “Many patients described a kind of peacefulness without the constant hubbub of modern life and the constant triggers they’re exposed to,” she said.

However, in response to the virus, the US government has done something unheard-of: it relaxed rules and regulations around prescribing methadone and buprenorphine, two commonly prescribed opioid addiction treatments. Patients no longer needed to attend daily in person appointments to receive their methadone prescriptions and could instead be given 4 weeks’ worth at a time. Doctors no longer need to meet in person to prescribe buprenorphine.

This was initially celebrated as a positive change, however as the pandemic has progressed and people have remained isolated, lockdown has become harmful to people with mental health issues and drug addiction disorders.

“Social isolation has always been a huge component of drug overdose risk,” said Traci Green, an epidemiologist at Brown University who studies drug abuse and addiction. “So much of what we’ve been trying to do has been completely unravelled.”

Experts have pointed to other dangers lockdown poses such as;

  • Lack of revival fall back from other users due to an increase in solo drug users
  • Less emotional support as in person visits are scaled back
  • Inconsistent drug strength and quality
  • Supply or income disruption leading to inconsistent drug use habits and accidental overdose

 

Randox Toxicology

Using our revolutionary Biochip Array Technology, the Evidence MultiSTAT is a fully automated benchtop analyser that enables onsite, simultaneous testing for up to 21 classical, synthetic or prescription drugs from a single sample in under 20 minutes. This quick and highly reliable technology makes it perfect for use in hospitals and medical centres, as pressure increases with the rising number of drug overdose deaths in the US.

 

To find out more about our Biochip Array Technology and our Evidence Series range of analysers, visit www.randoxtoxicology.com or email info@randoxtoxicology.com

Randox Toxicology Products and Services

BIOCHIP

EVIDENCE

ELISA

MATRICES

Want to know more about Randox?

Contact us or visit our homepage to view more.


RTS Blog: Use of Reporting Services in Medico-Legal Cases

19 October 2020: Use of Reporting Services in Medico-Legal Cases

At Randox Testing Services we provide several reporting options that are available for use should they be required in medico-legal cases, including expert witness reports and medical reviews to add clarity and expert examination to results.

Why is Drug and Alcohol Testing in Medico-legal Cases Important?

Drug and alcohol testing is important to ensure child protection from the detrimental effects of parental substance misuse and to ensure they have a quality of life they deserve. In addition, it is also important to enable parents the opportunity to get the help and support they need and begin rehabilitation treatment.

Doing the right thing by the child is the main priority, and where possible parent and child relationships are sought to be maintained. Drug and alcohol testing assists in these efforts and in such cases abstinence monitoring testing may be required to assess a parent’s recovery e.g. if a visitation case is being reassessed.

Expert Witness Services

An Expert Witness Report is an interpretation of the results of a drug or alcohol test. It provides a detailed explanation of whether substances tested for were detected as well as information regarding chain of custody compliance and testing procedures.

As trusted industry experts Randox Testing Services staff are trained to act as Expert Witnesses in legal cases involving drug and alcohol testing. Our experienced team of Reporting Scientists have undergone extensive Expert Witness training to provide professional witness statements or fully written reports for use as evidence in a court of law or industrial tribunals.

Where required a Senior Toxicologist from Randox Testing Services can attend legal proceedings in person to provide expert witness testimony.

Medical Review Officer

Our medical review service offers independent and expert examination of positive results under medical confidentiality.

A positive result from a drug and alcohol analysis is a cause for concern. However, there are some cases when there is a legitimate medical reason for the result. Our medical review service allows for the independent and confidential review of the result to determine the cause of a positive result, for example, if an employee is taking prescription medication.

The Medical Review Officer (MRO) assesses a positive result in the light of the donor’s medical background to determine if there is a legitimate medical reason for the result. The MRO helps protect both the rights of the employee being tested and the employer requiring the testing.

Randox Testing Services

At Randox Testing Services we offer customers access to our expertise through providing various reporting options to customers. These reporting services can be utilised in cases where extra clarity or examination is needed to investigate the outcome of a drugs test. These reports are utilised by workplaces as well as those operating within the medico-legal sector.

For more information on our training, education and reporting services, visit https://www.randoxtestingservices.com/workplace-drug-and-alcohol-testing/training-education-reporting-and-policy/

If you would like to find out more about our drug and alcohol testing programs, contact us today to speak to one of our experience business development executives.

Email: testingservices@randox.com

Phone: 028 9592 2801

 

 

Want to know more?

Contact us or visit our website to read more.


Randox response to comments within Sunday Times article 18th October 2020

Randox Logo

   

Randox response to comments within Sunday Times article 18th October:

Randox rejects comments made in the Sunday Times on 18th October, related to Randox’s contribution to the UK’s Covid-19 national testing programme, as misleading and inaccurate.

Randox have committed, through private investment, to the rapid growth of Covid-19 testing capacity within the UK. Indeed Randox are successfully operating at considerable scale and are currently providing well in excess of the testing capacity we have committed to the UK’s testing programme.

The vast majority of samples are reported within 24 hours of entering our laboratories.

Those samples that are found to be unsuitable for processing on receipt at our facilities, and are therefore voided, are not the responsibility of Randox. Such samples are voided when issues have arisen during sample collection and logistic processes, controlled by other parties.

It should also be noted that the proportion of samples found to be unsuitable on receipt at our facilities are both very low and comparable with all other laboratories across the programme.

Randox remain committed to supporting the UK’s Covid-19 testing programme and fully understand the importance of our work to the social and economic well being of the nation.

Press enquiries should be emailed to randox@newcenturymedia.co.uk 

 

 

Randox in the media

Latest News

FAQs


Randox delves into the inner workings of a racing driver’s body and mind for first-ever Goodwood SpeedWeek

News       Randox Health Packages        Testimonials

 

13 October 2020

Randox delves into the inner workings of a racing driver’s body and mind for first-ever Goodwood SpeedWeek

Goodwood SpeedWeek will bring fans closer to the action than ever before with a one-off digital technology playground that viewers can experience from the comfort of their own homes – and Randox will feature as part of the event with a documentary showing the inner workings and hidden brilliance of a racing driver’s mind and body under stress.

Being shown on Saturday 17 October, ‘The Racing Mind’ documentary looks at the psychological, physiological and chemical make up of racing drivers.

Millions of spectators will be able to enjoy 360-degree audio-visual displays, take a virtual paddock tour, use chatroom functionality to question their favourite drivers, and interact with the action through quizzes, polls, competitions and a ‘podium predictor’.

Goodwood Speedweek, which runs from 16-18 October 2020, is the most ambitious event to ever take place at the Goodwood Motor Circuit with more than 12 miles of high-speed fibre cabling being laid and 49 high-definition cameras installed, including 19 trackside cameras and 15 live on-boards. A television crew of 180 operators will help bring the action to life with 10 presenters and two TV studios required to cover all the action.

Each day will be dedicated to celebrating the automotive industry’s past, present and future – bringing together the best elements of the Festival of Speed and Revival using the latest technology.

This will be reflected in the iconic Goodwood Shootout presented by Mastercard on Sunday 18 October, with a winner-takes-all one-lap competition between some of the fastest machines in motorsport across the years, including hypercars, single-seaters and prototype sports cars.

The Duke of Richmond said;

“Technology is a core feature of Goodwood motorsport events and we strive to showcase the most innovative and forward-thinking mobility innovations. At Goodwood SpeedWeek we were presented with a unique opportunity to go one step further, quite literally placing digital right at the heart of the experience. It’s allowed us to raise the bar even higher, offering a once in a lifetime, interactive experience that is accessible to viewers anywhere in the world.”

The Racing Mind (Saturday 17th October)

In partnership with Randox, Goodwood Speedweek will show viewers the inner workings and hidden brilliance of a racing driver’s mind and body under stress.

The Technology Showcase (Sunday 18th October)

  • The first autonomous lap: Einride will undertake an autonomous lap on the Goodwood Motor Circuit including a behind-the-scenes look at how it was achieved.
  • F1 Technology: Before taking to the track to celebrate 70 years of F1, there will be a live grid walk of cars charting the evolution of technology in F1 through the ages.
  • Car vs Bike vs Drone: An all-electric race between the Virgin Formula E, Electric Harley and Drone racer on the Driftkhana course.
  • Jet Suit: A look behind-the-scenes of Gravity and how you train to become a jet suit pilot, followed by a unique race between three jet racers.
  • Ford Electric Mustang: The all-electric Mach-E Mustang 1400 prototype will take to the track for a drift demonstration.
  • Sennheiser: An interactive demonstration of 360-degree binaural audio, live from the heart of the event.

Fans can sign up for alerts at: https://www.goodwood.com/motorsport/goodwood-speedweek/

As well as streaming options through goodwood.com and social media, SpeedWeek will be broadcast live on ITV1 and ITV4 during the event;

  • Friday 16th Oct – 16:30-18:30 (ITV4)
  • Saturday 17th Oct – 14:00-16:00 (ITV4)
  • Sunday 18th Oct – 14:00-16:00 (ITV1)

A selection of highlight programmes the week after the event on ITV4;

  • First Glance – Wednesday 21st Oct – 21:30
  • Highlights 1 – Thursday 22nd Oct – 20:00
  • Highlights 2 – Thursday 22nd Oct – 21:00

Stay up to date with all future announcements and on-event action with the official hashtag #gwspeedweek across Goodwood social channels:

 

Want to know more?

Contact us or visit our Randox Health page to view more.

Our Randox Health programmes

Everyman

Everywoman

Signature

Specialised testing


EU Traffic Light System: How to get a COVID-19 PCR test before travelling

12 October 2020

EU Traffic Light System: How to get a COVID-19 PCR test before travelling

EU Traffic Light System: How to get a COVID-19 PCR test before travelling

As Covid-19 infection rates continue to rise in many parts of the world, an increasing number of countries are asking for a negative PCR test as a means of proof that travellers do not have the Covid-19 virus.

Whilst not yet a common requirement globally, it is understood that the EU could soon be turning to a Traffic Light System that will require pre-departure testing for individuals departing any of the 15 ‘red list’ countries – which includes the UK and could be extended to include Ireland.

Whilst there are currently a number of countries across the EU that do not require a negative COVID test for visitors from the UK, the implementation of this co-ordinated approach across the EU will place common requirements on all travellers from the UK, no matter which country they are visiting.

It could also be used in support of reduced quarantine in those countries which require it.

So – what is a PCR test?

PCR stands for Polymerase Chain Reaction and is a method of testing used to detect infectious disease, including COVID-19.

A PCR test is performed in a laboratory and is indicative of an individual’s COVID status at the time their sample is taken. It does not show previous infection.

Where can I get a COVID PCR test done?

PCR tests are available at Randox Health via an in-clinic appointment, or a home sample collection.

Are home tests accepted as proof of my COVID status?

It is important to note that many countries do not accept ‘home tests’ as proof of a negative COVID-19 result. Results must show that the test was performed in a certified laboratory.

Whilst Randox Health offers a home sample collection kit, all our testing is performed using PCR methods in our certified laboratories.

If the country you are travelling to requires a PCR test result, we’ve got you covered.

How do I know if I need a COVID PCR test?

You can check the entry requirements for your destination at gov.uk/foreign-travel-advice

Requirements are subject to change, so keep checking in the weeks and days leading up to your trip.

When do I take my sample for testing?

Your destination country will determine the time frame required for testing. For example, it may state that your sample needs to be taken and tested within 72 hours before departure / arrival. You cannot be swabbed before this time.

It is best to book / order your test in advance and take it as early as possible within your window, so that you allow for the maximum amount of time to get your test results back.

How long do I wait for my results?

Upon receipt of sample at Randox’s laboratories, you will receive your results within 24 hours.

Our rapid, accurate and reliable COVID-19 testing service will help get your trip off to a hassle-free start, with minimum disruption to your travel plans.

Visit https://www.randoxhealth.com/covid-travel-certificate/ to order your home sample collection kit or book your clinic appointment.

For further information please email info@randoxhealth.com or phone 0800 2545 130.

     

    Want to know more about Randox?

    Contact us or visit our homepage to view more.

    Our COVID-19 Products and Services

    HOME TEST

    ANTIBODY TEST

    TRAVEL CERTIFICATE

    LABORATORY TOOLS


    We Are Randox | How Courtney became a COVID-19 Scientist and Trainer

    08 October 2020

    We Are Randox | How Courtney became a COVID-19 Scientist and Trainer

    In support of our new £30m COVID-19 laboratories, we are recruiting across Engineering, Manufacturing and Science.

    For an idea of what it’s like to be part of the COVID-19 testing programme at Randox, we spoke to Senior Scientist and Trainer Dr Courtney Ward.

    Courtney spoke to us about what a typical day in our laboratories looks like, the career path she took to her current role, and how it feels to be making a difference in the global fight against COVID-19.

    Name: Dr Courtney Ward

    Job Title: Senior COVID-19 Scientist and Trainer

    Department: COVID-19 Laboratories

    Give a brief outline of your career to date.

    During my undergrad studies, I spent a year working on developing drug delivery technologies for a pharmaceutical company in England. Then during my PhD I worked in the Research Funding team at Cancer Research UK, and subsequently, following the completion of my PhD, at the Centre for Cancer Research and Cell Biology at Queen’s University Belfast.

    My next move led me to Randox, to work on new ways to diagnose a range of diseases.

    What was your favourite subject at school?

    At school I always enjoyed science, and in particular biology. Since a child I have been fascinated with how the human body works and how different diseases can affect this.

    Did you go on to further/higher education, if so what did you study and where?

    I studied for eight years at Imperial College London. This included an undergraduate in Biochemistry, a Masters degree in Structural and Molecular Biology, and finally, a PhD in Structural Biology/Biophysics, for which I studied how bacteria affect human cells during infection.

    How did you get into your area of work?

    As I had previous experience in infectious disease testing, I moved this year into the Randox COVID-19 team to help respond to the urgency of the situation. As our testing capacity, and subsequently our staffing levels, have increased so extensively, I also use my experience to train our new scientists, which is something I really enjoy.

    Is this what you always wanted to do?

    I have always loved science and knew my career would be within this sector. I also enjoy teaching and training, so being a COVID-19 trainer has combined my two favourite roles into one which has been great.

    Were there any particular essential qualifications or experience needed?

    Scientists involved in COVID testing will be exposed to molecular testing techniques including DNA extraction, PCR techniques and Biochip technology, so experience in these areas is advantageous. There are also a number of positions – like accessioning or administration – that do not require a science background and we include all the training needed for these roles.

    What are the main personal skills your job requires?

    For roles in testing, the most important skills are concentration and attention to detail. We deal with 1000s of samples in a shift so it is crucial to manage each one carefully as the results are so important to each individual patient. You also need to be a team player, focused and able to take initiative.

    What does a typical day entail?

    A typical day in our COVID-19 laboratory begins with a handover from the previous shift and then we are assigned our roles for the day. You may spend your day preparing reagents using liquid handling robots, or you may be involved in organising samples along with their corresponding paperwork. It is a varied and exciting role, as things move very quickly in the world of COVID-19 testing.

    What are the best and most challenging aspects of the job?

    The best thing about working in the Randox COVID labs is knowing you are contributing to the national testing effort and therefore making a real difference. Working with a team is great and gives you the chance to meet a lot of new people for a lot of different backgrounds. I also really enjoy seeing new scientists improve in confidence during their training. Seeing them working well on shift gives me great sense job satisfaction.

    The most challenging aspect of COVID testing can be the time pressure, as getting results out to the patient as fast and accurately as possible means teams must work seamlessly together. Similarly with training, we need to ensure we have enough staff to support our testing labs and so this can lead to a lot of new staff needing training which we need to work through quickly and efficiently.

    Why is what you do important?

    COVID-19 has had a huge impact on every aspect of our lives. To be involved in testing, which is absolutely crucial in identifying clusters of infection and reducing further spread, is so important to me and spurs me on to work to the absolute best of my ability.

    What advice would you give anyone looking to follow a similar career path?

    For me, making sure you take any opportunity to further your development is critical, be it the prospect of learning a new technique or method, or the chance to join the fight against COVID-19! I have always jumped at the chance to learn something new and this has set me in good stead for my current role as a trainer.

    If you weren’t doing this what would you like to do?

    If I weren’t involved in laboratory work, I would still carry on my love of science and training, by teaching science. I have always loved teaching, and I tutor in my spare time – to inspire the next generation to study and work in STEM subjects.

    What is the one piece of advice you would give to yourself on your first day?

    Take in as much information as possible – there will be a lot of it! Ask as many questions as you can, particularly if you are unsure of anything.

    Describe your ideal day off.

    Catching up on Real Housewives and taking my dog to the beach for a swim.

    And finally, what’s the key to any successful job search?

    Make sure you read the job description and tailor your CV to each role to which you apply. Make it easy for the employer to see how your skills and experience meet the criteria for the job.

    We are delighted to have Courtney with us at Randox as part of our COVID-19 testing programme.

     

    For current vacancies at Randox please visit randox.getgotjobs.co.uk

    For more We Are Randox stories about our amazing colleagues, make sure to follow us on Facebook, Instagram and Twitter and follow the hashtag #WeAreRandox.

    For further information please email recruitment@randox.com or phone 028 9442 2413.

     

    Want to know more?

    Contact us or visit our Randox Careers

    Find out more about Randox Careers

    News

    Vacancies

    Our Team

    Staff Profiles


    New 39-minute COVID test available on Randox-Bosch Vivalytic

    News       About Us       SARS-CoV-2 Rapid Test

     

    02 October 2020

     

    New 39-minute COVID test available on Randox-Bosch Vivalytic

    • The world’s fastest PCR based SARS-CoV-2 test for the point of care delivers reliable results in 39 minutes.
    • Has a sensitivity of 98 percent and a specificity of 100 percent.
    • Simultaneous testing of five people with one cartridge by pooling will be available from early October.
    • Work is in progress to further reduce time to result.

    A rapid new coronavirus test, which provides results for Covid-19 in just 39 minutes, is now available on the Vivalytic, a point of care platform brought to market by Randox Laboratories and Bosch.

    The test for detection of the SARS-CoV-2 pathogen, is currently the fastest PCR test (the gold standard of test methods) worldwide, and is predestined for decentralized use in mobile test centres at service stations or in airports, so that people who take the test can obtain a reliable result while at the testing site.

    Available now in Europe, the CE-approved test, which has a sensitivity of 98 percent and a specificity of 100 percent, helps avoid time in quarantine, relieve laboratories, and make travel and work safer again.

    “Rapid and accurate testing plays a crucial role in identifying cases of Covid-19 – to contain any outbreaks and limit the spread of the virus,” says Dr. Heather McMillan, Molecular R&D Manager at Randox Biosciences.

     “This new rapid test will be a game-changer in the coronavirus testing landscape by allowing patients to receive their results at the point of care faster than ever before.”

    Randox and Bosch launched the first rapid test for the Vivalytic analyser at the end of March, after just six weeks’ development.

    As a multiplex test, it simultaneously checks samples for the SARS-CoV-2 virus as well as nine other respiratory diseases in two and a half hours, whereas the new accelerated test is exclusively for SARS-CoV-2.

    “With our different coronavirus tests and variable analysis strategies, we open up a range of testing scenarios with a Vivalytic device – from screening all the way to supporting differential diagnosis for similar symptoms,” says Marc Meier, president of Bosch Healthcare Solutions GmbH.

    And development work for Covid tests on the Vivalytic is ongoing: as of early October 2020, by pooling samples together it will be possible to simultaneously evaluate five samples in one test cartridge and at a comparable speed – a world first.

    This will increase available testing capacity, by enabling fully automated processing of more than 160 samples a day using a Vivalytic device.

    Key Benefits of SARS-CoV-2 test on Vivalytic point of care platform

    The advantages of the rapid SARS-CoV-2 test on Vivalytic lie not only in speedy analysis, but also in ease of use. A sample is taken from the nose or throat using a swab, and placed in the test cartridge. Then the cartridge, which contains all the reagents required for the test, is inserted into the Vivalytic device for automated analysis.

    • Turnaround time of 39 mins from sample entry to result.
    • The SARS-CoV-2 rapid test has recently received CE marking.
    • The SARS-CoV-2 pooling test can run up to 5 samples on-board one single cartridge.
    • Easy 4-step user-friendly process from sample entry to result. Minimal training required.
    • Detection from real-time PCR from Nasopharyngeal and/or Oropharyngeal swab.
    • Suitable for use in any laboratory and non-laboratory settings.

    The development of the new Vivalytic PCR singleplex test is part of a research and development project funded by the German Federal Ministry of Education and Research (BMBF).

    For more information please contact marketing@randox.com

    RESEARCH

    BIOPHARMA

    CLINICAL LAB

    BIOREAGENTS


    Request a meeting
    ×
    Make an Enquiry - RX series
    ×
    Make an Enquiry - Reagents
    ×
    Kit Insert Request - Reagents
    • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
    ×
    Kit Insert Request - Reagents
    • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
    ×
    Make an Enquiry - Reagents
    ×
    Make an Enquiry - Quality Control
    ×
    Make an Enquiry - RIQAS
    ×
    Make an Enquiry - RIQAS
    ×
    Make an Enquiry - Quality Control
    ×
    Make an Enquiry
    • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
    ×
    Make an Enquiry - Biochip
    • This field is for validation purposes and should be left unchanged.
    ×
    Make an Enquiry - Molecular
    • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
    • This field is for validation purposes and should be left unchanged.
    ×
    Make an Enquiry - Future Diagnostics
    ×
    Make an Enquiry - RX series (Product)
    ×
    Make an Enquiry - Quality Control
    • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
    ×
    Make an Enquiry - RIQAS
    • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
    ×
    Make an Enquiry - Reagents
    • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
    ×
    Por favor, introduzca sus datos para ver nuestro último seminario
    ×
    Wyślij zapytanie